Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access |
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc |
Journal website https://www.jocmr.org |
Review
Volume 12, Number 12, December 2020, pages 780-786
Advanced Therapy Medicinal Products Challenges and Perspectives in Regenerative Medicine
Figure
Tables
Classification | Definition | Applications |
---|---|---|
ATMPs: advanced therapy medicinal products; ALS: amyotrophic lateral sclerosis. | ||
Gene-based therapeutic medicinal products | Gene transfer-based approaches which are leading to therapeutic, prophylactic or diagnostic effect. | Inherited disease |
Cancer therapy | ||
Tissue regeneration (e.g., lost of sight) | ||
Somatic cell therapeutic medicinal products | Cell-based approaches which are including in vitro manipulating cells or tissues with therapeutic, prophylactic or diagnostic effect. | Products against immune disease |
Parkinson’s disease, ALS, Alzheimer’s disease | ||
Cartilage defect | ||
Product for cardiac repair | ||
Skin replacement | ||
Cancer immunotherapy | ||
Tissue-engineered medicinal products | Tissue engineered-based approaches that can be applied to repair, regenerate or replace human tissues or organs. | Small diameter vascular grafts |
Trachea replacement | ||
Tissue-engineered esophagus | ||
Liver and kidney implantation | ||
Nerve conduits |
Advance therapy medicinal products borderlines | |
---|---|
Advantages | Disadvantages |
ATMPs: advanced therapy medicinal products. | |
Highly personalized therapy | Complex manufacturing |
Direct application through infusion | High up-front cost |
Longer lasting effect | One-time treatment |
Address complex diseases | Specific regulatory and pharmacovigilance demands |
Improving health-related quality of life | Highly specific storage requirements: short shelf life |
Fewer hospitalizations, comorbidities and associate treatment |